A major contributor to this article appears to have a close connection with its subject. (May 2022) |
Maria C. Freire is a Peruvian-American biophysicist who was the president and executive director of the Foundation for the National Institutes of Health (FNIH) from 2012-2021. She also is a member of the U.S. National Academy of Medicine and Council on Foreign Relations. Freire works in global health, technology commercialization and intellectual property management, focusing on the discovery, development and access to medical interventions.[1][2]
Maria C. Freire | |
---|---|
![]() | |
Born | |
Nationality | American |
Occupation(s) | Former President and Executive Director of the Foundation for the National Institutes of Health |
Education
editA native of Lima, Peru,[3] Freire trained at the Universidad Peruana Cayetano Heredia.[4] She received a Ph.D. in biophysics from the University of Virginia[4] and completed postgraduate work in immunology and virology at the University of Virginia and at the University of Tennessee,[5] respectively, and at the John F. Kennedy School of Government, Harvard University. She is the recipient of a Fulbright Fellowship[3] as well as two AAAS Congressional Science Fellowships,[6] sponsored by the Biophysical Society and the American Society for Photobiology.
Career
editFreire was the president of the Albert and Mary Lasker Foundation.[7] From 2001 to 2008, she was the president and chief executive officer of the Global Alliance for TB Drug Development,[8] a not-for-profit organization that develops drugs to fight tuberculosis.
Freire directed the Office of Technology Transfer at the National Institutes of Health from 1995 to 2001,[9] where she oversaw the transfer of federally funded technology from the not-for-profit sector to the for-profit sector.[10] Prior to that, Freire established and headed the Office of Technology Development at the University of Maryland, Baltimore and the University of Maryland, Baltimore County.[11]
Other activities
editFreire was a member of the Leadership Group of Accelerating COVID-19 Therapeutics and Vaccines (ACTIV).[12] She was a member of the Science Board of the U.S. Food and Drug Administration (FDA) and served as chair from 2013 to 2015;[13] is the chair of the business advisory board of the Institute for Biomedical Research, Barcelona, Spain[14] has served as a member of the Commission on the Global Health Risk Framework for the Future of the National Academy of Medicine and the executive committee of the United Nations’ Sustainable Development Solutions Network.[15] Freire also served as a member of the UN Secretary General High Level Panel on Access to Medicines.[16] She also was selected as one of ten commissioners of the World Health Organization's Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH)[17] and served as a member on the International Advisory Committee for the Carlos Slim Health Institute.[18]
In 2008, Freire was elected to the Institute of Medicine (National Academy of Medicine)[19] and is currently a member of its Cecil Awards Selection Committee. Freire was elected to the Council on Foreign Relations in 2009[20] and serves on its Committee on Membership.[21] She serves on the Board of Directors of Exelixis, Inc.,[22] and since April 2012, has served as a director on the board of the Alexandria Real Estate Equities, Inc.[23]
Selected awards
edit- 2017 Washington Business Journal's Women Who Mean Business Award[24]
- 2017 Stevie Award for Woman of the Year in the government/nonprofit category[25]
- 2019 NonProfit PRO "Executive of the Year" Award,[26]
- 2023 Great Immigrants Award Honoree, Carnegie Corporation of New York[27]
References
edit- ^ "NIH Director Welcomes Three New Members to the Advisory Committee to the Director". National Institutes of Health (NIH). 29 August 2015. Retrieved 29 April 2018.
- ^ "Nonprofit PRO Executive of the Year". Nonprofit PRO.
- ^ a b Taking the Road That Transforms nyas.org Winter 2009 p.9
- ^ a b LinkedIn profile [self-published source]
- ^ "WHO | Dr Maria Freire". Archived from the original on 9 July 2004.
- ^ Maria Freire To Direct Technology Transfer NIH Record, Vol. XLVII, No. 3 January 31, 1995 p.1
- ^ "Lasker Foundation Appoints Global Health Leader as New President" (PDF). www.laskerfoundation.org. Retrieved 26 June 2019.
- ^ "Maria Freire Appointed CEO". www.tballiance.org. August 2001. Retrieved 26 June 2019.
- ^ "Biographical Sketches of Commission Members, Consultants, and Staff". NCBI. National Academies Press (US). 16 May 2016.
- ^ "Freire To Return to Area to Head FNIH". NIH Record.
- ^ "Dr Maria Freire". WHO. Archived from the original on 9 July 2004.
- ^ "NIH Launches Partnership to Speed COVID-19 Vaccine, Treatments". 15 May 2020.
- ^ "Mission Possible". FDA.
- ^ "Maria Freire". IRB Barcelona.
- ^ "The Neglected Dimension of Global Security" (PDF). NAS.
- ^ "High-Level Panel on Access to Medicines". United Nations.
- ^ "WHO announces the membership of the Commission on Intellectual Property Rights, Innovation and Public Health". WHO. Archived from the original on 26 August 2004.
- ^ "International Advisory Committee". Carlos Slim Foundation.
- ^ "Institute of Medicine Elects 65 New Members, Five Foreign Associates - Institute of Medicine". Archived from the original on 23 March 2009. Retrieved 27 June 2009.
- ^ "Archived copy" (PDF). Archived from the original (PDF) on 26 October 2009. Retrieved 28 October 2009.
{{cite web}}
: CS1 maint: archived copy as title (link) - ^ "Board of Directors".
- ^ "Exelixis' Board of Directors". Exelixis.
- ^ Meet our team are.com
- ^ Van Zandt, Emily. "Meet our 2017 Women Who Mean Business honorees". www.bizjournals.com.
- ^ "2017 Stevie Award Winners – Stevie Awards". stevieawards.com. 5 October 2017.
- ^ "Executive of the Year". nonprofitpro.com.
- ^ "Maria Freire". Carnegie Corporation of New York. 2023.